Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rubedo Life Sciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Rubedo Life Sciences

Rubedo Life Sciences

Rubedo Life Sciences, a biopharmaceutical firm, innovates therapies targeting age-related diseases using its ALEMBIC platform.

HQ
Sunnyvale, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Rubedo Life Sciences, founded with a mission to combat chronic age-related diseases, leverages its proprietary ALEMBIC drug discovery platform to develop innovative therapies. The company focuses on creating first-in-class small molecules that selectively target senescent cells, which contribute to conditions such as pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo aims to transform the treatment landscape for these chronic conditions through its cutting-edge biopharmaceutical solutions.

Notable investors in Rubedo Life Sciences include Khosla Ventures and Ahren Innovation Capital, who led a $40 million Series A financing round. The company has also formed a significant partnership with Beiersdorf to develop new skincare products addressing cellular aging. Among its key achievements is the nomination of its first-in-class disease-modifying candidate RLS- in dermatology. Rubedo's innovative approach and strategic collaborations have positioned it as a promising player in the biopharmaceutical industry, making substantial strides in targeting age-related diseases.

Rubedo Life Sciences - Similar Companies

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Retro Biosciences logo

Retro Biosciences

retro.bio

Gerostate Alpha logo

Gerostate Alpha

Regenerative Bio logo

Regenerative Bio

regen-bio.us

BioAge Labs logo

BioAge Labs

bioagelabs.com

Cambrian BioPharma logo

Cambrian BioPharma

cambrianbio.com

Spring Discovery logo

Spring Discovery

Rediscovery Life Sciences logo

Rediscovery Life Sciences

rediscoveryls.com

Longeveron logo

Longeveron

longeveron.com

AgeX Therapeutics logo

AgeX Therapeutics

EdenRoc Sciences logo

EdenRoc Sciences

Deciduous Therapeutics logo

Deciduous Therapeutics

deciduoustx.com

Alveolus Bio logo

Alveolus Bio

alveolusbio.com

Juvenescence logo

Juvenescence

juvlabs.com

Oisin Biotechnologies logo

Oisin Biotechnologies

oisinbio.com

Rubedo Life Sciences - Quick Facts

Who are Rubedo Life Sciences' competitors?

Companies similar to Rubedo Life Sciences include Rejuveron Life Sciences, Retro Biosciences, Gerostate Alpha and Regenerative Bio.

When was Rubedo Life Sciences founded?

Rubedo Life Sciences was founded in 2018.

Where is Rubedo Life Sciences' headquarters located?

Rubedo Life Sciences' headquarters is located in Sunnyvale, CA, US.

How much has Rubedo Life Sciences raised to-date?

As of Oct 31, 2023, Rubedo Life Sciences has raised a total of $13.4M (USD).

How many employees does Rubedo Life Sciences have?

Rubedo Life Sciences has 28 employees as of Feb 4, 2024.

Rubedo Life Sciences - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research